ATIXF yields 14285.71% · JNJ yields 2.13%● Live data
📍 ATIXF pulled ahead of the other in Year 1
Combined, ATIXF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ATIXF + JNJ for your $10,000?
AnalytixInsight Inc. operates as a data analytics and enterprise software solutions provider to worldwide institutions across various industries. It develops and markets cloud-based platforms, providing financial content, stock trading, and research solutions for banks, brokers, and investors in the financial services industry. The company also holds a 49% interest in Marketwall SRL, a developer of FinTech solutions for financial institutions. In addition, it offers financial research and content for investors, information providers, finance portals, and media through its online portals and Connect platform; and system integration services for the workforce management industry. The company was formerly known as OMT Inc. and changed its name to AnalytixInsight Inc. in July 2013. AnalytixInsight Inc. was incorporated in 1999 and is headquartered in Toronto, Canada.
Full ATIXF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.